Completed

Limit: 3 // Tickets Available: 2 

A. Dhar (Animal and Comparative Biomedical Sciences)

The objectives of the S-K Program and, therefore, the funding priorities for the S-K Grant Competition, have changed over the years since the program began in 1980. The program has evolved as Federal fishery management laws and policies and research needs have evolved in response to changing circumstances.

The Magnuson-Stevens Fishery Conservation and Management Act requires fishery managers to undertake efforts to prevent overfishing, rebuild overfished fisheries, ensure conservation, minimize by-catch, protect essential fish habitats, and realize the full potential of U.S. fishery resources. It further requires that the Federal government take into account the importance of fishery resources to fishing communities; provide for the sustained participation of such communities; and, to the extent possible, minimize the adverse economic impacts of conservation and management measures on such communities.

The objective of the S-K Research and Development Program, referred to throughout this document as the S-K Program, is to promote U.S. fisheries by assisting the fishing community to address marketing and research needs.

NMFS seeks applications that demonstrate direct benefits to U.S. fisheries and meaningful participation of fishing communities . The S-K Grant Competition is open to applicants from a variety of sectors, including individuals, industry, academia, and state and local governments.

Limit: 1  // PI:  J. Denno (Cyber Convergence Center)  - Competitive Resubmission

Only one application per institution is allowed.

The Department of Defense (DoD) Cyber Scholarship Program (CySP) is authorized by Chapter 112 of title 10, United States Code, Section 2200. The purpose of the program is to support the recruitment of new cyber talent and the retention of current highly skilled professionals within the DoD cyber workforce. Additionally, this program serves to enhance the national pipeline for the development of cyber personnel by providing grants to institutions of higher education. The DoD Cyber and Digital Services Academy (DCDSA) will partner with the DoD CySP/DCDSA in 2024.

Regionally and nationally accredited U.S. institutions of higher education, designated under the National Centers of Academic Excellence in Cybersecurity (NCAE-C) and known as National Centers of Academic Excellence in Cyber Defense, Research, and/or Cyber Operations (hereinafter referred to as NCAE-Cs) are invited to submit proposals for developing and managing a full-time, institution-based, grant-funded scholarship program in cyber-related disciplines for Academic Year 2024- 2025. NCAE-Cs may propose collaboration with other accredited institutions, and are encouraged to include accredited post-secondary minority institutions. NCAE-Cs must be in good standing with the NCAE-C Program Office and not be delinquent on any required documentation by the NCAE-C Program Office.

Consistent with 10 U.S.C. 2200b, NCAE-C proposals to this solicitation may also request modest collateral support for purposes of institutional capacity building to include faculty development, laboratory improvements, and/or curriculum development, in cyber-related topics to providing a strong foundation for a DoD CySP/DCDSA/DCDSA. [Special note: Requirements for proposing modest capacity building support are detailed in ANNEX II.]

To continue the development of a strong foundation for recruitment scholarship program during the Academic Year 2024-2025, students falling into one of the following categories may apply:

• • Rising second-year NCAE-C Community College students who will be transitioning into a bachelor’s degree program at a 4-year NCAE-C
• • Current individuals who hold a non-cyber related bachelor’s or graduate degree, cross training into cyber by pursuing an associate’s degree.
• • Juniors or Seniors pursuing a bachelor's degree (Sophomore's promoting to a Junior in Fall 2024 are eligible to apply)
• • Students in their first or second year of a master's degree; or
• • Students pursuing doctoral degrees.

Traditional National Guardsmen and reservists are eligible to apply under the recruitment program. Current DoD civilians and active duty military members are only eligible for the retention program. Applications for the retention program are processed under a different memorandum. NCAE-C are not required to forward or handle retention student applications. These individuals may also participate in the retention community college program.

Reserve Officer’s Training Corps (ROTC) participants are eligible to apply as long as they do not currently have a service obligation with their ROTC activities.

Limit: 1  // PI: L. Folks (Semiconductor Strategy)  

Only one application per institution is allowed.

In support of the Department of State implementation of the International Technology Security and Innovation (ITSI) Fund, appropriated under the Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022, ISN/CTR will sponsor activities to secure semiconductor supply chains and mitigate risks that some uses of advanced semiconductors can pose to national and international security.

The Department of State’s Bureau of International Security and Nonproliferation, Office of Cooperative Threat Reduction (ISN/CTR) is pleased to announce an open competition for assistance awards through this Notice of Funding Opportunity (NOFO). ISN/CTR sponsors foreign assistance activities funded by the Nonproliferation, Antiterrorism, Demining and Related Programs (NADR) and other accounts, and focuses on mitigating weapons of mass destruction (WMD) and WMD-related delivery systems proliferation and security threats from non-state actors and proliferator states. An underlying aim of all ISN/CTR’s efforts is long-term sustainability to maximize programmatic impact while minimizing the need for foreign partners to rely on outside financial or technical assistance.

Limit: 1*// H. Kavan (Aerospace and Mechanical Engineering)  

*UA may submit one proposal under the Research Partnerships track. There is no institutional limitation on the Technology Translation track.

If you don’t have a demonstrated and substantial industry relationship as required for a PFI submission, please reach out to Brian Adair(link sends e-mail) or Lindsay Ridpath(link sends e-mail), to help develop those connections so that your proposal is competitive. PFI proposals are accepted three times per year and you may be better served by strengthening your industry relationship and waiting for the next cycle.


The Partnerships for Innovation (PFI) Program within the Division of Translational Impacts (TI) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit.

The Research Partnerships (PFI-RP) track seeks to achieve the same goals as the PFI-TT track by supporting instead complex, multi-faceted technology development projects that are typically beyond the scope of a single researcher or institution and require a multi-organizational, interdisciplinary, synergistic collaboration. A PFI-RP project requires the creation of partnerships between academic researchers and third-party organizations such as industry, non-academic research organizations, federal laboratories, public or non-profit technology transfer organizations or other universities. Such partnerships are needed to conduct use-inspired research on a stand-alone larger project toward commercialization and societal impact. In the absence of such synergistic partnership, the project’s likelihood for success would be minimal.

The intended outcomes of both PFI-TT and PFI-RP tracks are: a) the commercialization of new intellectual property derived from NSF-funded research outputs; b) the creation of new or broader collaborations with industry (including increased corporate sponsored research); c) the licensing of NSF-funded research outputs to third party corporations or to start-up companies funded by a PFI team; and d) the training of future innovation and entrepreneurship leaders.


 

The please be aware of important revisions in the PFI program recently announced in solicitation NSF 23-538, as outlined below:

NSF Lineage Requirement
Innovation Corps (NSF I-CorpsTM) Teams awards no longer convey the lineage required to submit a PFI proposal.
All proposals submitted to the PFI program must meet a lineage requirement by having NSF-supported research results in any field of science and engineering: Principal Investigator (PI) or a co-PI must have had an NSF award that ended no more than seven (7) years prior to the full proposal deadline date or be a current NSF award recipient. The proposed technology development project must be derived from the research results and/or discoveries from this underlying NSF award.

Award Information
The funding amounts in both tracks of the PFI program have significantly increased. Specifically:

• PFI-Technology Translation (PFI-TT) projects will be funded for up to $550,000 for 18-24 months per award; and

• PFI-Research Partnerships (PFI-RP) projects will be funded for up to $1,000,000 for 36 months.
   

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution is allowed. Applicants can only apply for funding under one funding opportunity number, either HRSA-24-042 (DPs) or HRSA-24-041 (NCCT). Applicants applying for the HRSA-24-042 (DPs) may only apply for one focus area, autism or epilepsy, and must clearly state the focus area for which they are applying. HRSA will not consider funding applicants who apply to more than one funding opportunity number or focus area.

This notice announces the opportunity to apply for funding under the Transition3 for Youth with Autism and/or Epilepsy program, which includes the Transition for Youth with Autism and/or Epilepsy Demonstration Projects (DPs) (HRSA-24-042) and the National Coordinating Center on Transition (NCCT) (HRSA-24-041). The purpose of this program is to develop and advance national, state, and local/community-level frameworks that support successful transition from child to adult serving systems4 for youth with autism and/or epilepsy who have complex health and social needs and require a higher level of family support and coordination (YAES).5 This announcement includes instructions for applying to two separate awards. You may only apply for HRSA-24-042 (DPs) or HRSA-24-041 (NCCT), but not both projects. HRSA will not consider funding applicants who apply to more than one funding opportunity number or focus areas.

The goal of this program is to improve outcomes including quality of life and well-being for YAES and their families/caregivers transitioning from child to adult systems. These systems include but are not limited to post-secondary education, inclusive post-secondary education, employment, community, independent/daily living, and healthcare.6 The target population for this program is characterized as YAES between the ages of 13 and 26 who have co-occurring conditions, intellectual disabilities, experience challenges in social cognition, communication, interpersonal skills, and/or behaviors7 8 9 and require a higher level of family support and coordination.

HRSA-24-041 (NCCT): One NCCT will be funded to support the HRSA-24-042 (DP) recipients in meeting their program objectives, and to provide national leadership to improve transition outcomes for YAES and their families/caregivers through training, technical assistance, evaluation, and the development and dissemination of resources to transition stakeholders,11 including Title V programs.

Applicants can only apply for funding under one funding opportunity number, either HRSA-24-042 (DPs) or HRSA-24-041 (NCCT). Applicants applying for the HRSA-24-042 (DPs) may only apply for one focus area, autism or epilepsy, and must clearly state the focus area for which they are applying.7 HRSA will not consider funding applicants who apply to more than one funding opportunity number or focus area.

 Limit: 1 // G. Valdez ( Global Health Programs)

The foundation will not consider more than one proposal from an organization in any calendar year. UArizona is not eligible again until the July 1, 2024 due date.

The Conservation, Food and Health Foundation seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East. 

The Foundation supports projects and applied research that:

• Generate local or regional solutions to problems affecting the quality of the environment and human life;
• Advance local leadership and promote professional development in the conservation, agricultural, and health sciences;
• Develop the capacity of local organizations and coalitions; and
• Address challenges in the field. 

The Foundation prefers to support projects that address under-funded issues and geographic areas.

The Foundation funds applied research, pilot projects, new initiatives, training, and technical assistance, rather than ongoing support for programs that are already well underway.  An important goal for the Foundation is to provide seed money to help promising projects, organizations, and individuals develop the track record they need to attract major foundation funding in the future.It is anticipated that most grants will fall in the $25,000-$50,000 per year range.

Areas of Interest 

The Conservation, Food & Health Foundation supports special projects and programs of non governmental organizations in three primary fields of interest: conservation, food, and health. Examples of areas of interest within these fields follow, but are not meant to be exclusive.

Conservation

• Conservation grants help improve ecological and environmental conditions in the developing world. The foundation supports field research and related research activities, training, and technical assistance efforts that:
• help conserve viable ecosystems and protect biological diversity in developing countries
• train local leaders in conservation and protection of resources, with an emphasis on technical and scientific training

Food

Food grants support focused efforts to improve access to food for consumption in developing countries. Areas of interest include projects that:

• promote or develop specific sustainable agriculture practices with potential to advance science and practice in other countries;
• explore and refine innovative education and training interventions for small scale food producers and farmers; and
• advance new approaches to control pests and diseases affecting important food crops of developing countries

Health

The foundation supports public health programs that are preventive rather than curative in nature. It supports research, technical assistance, and training projects that:

• improve public health through community-based efforts that address health promotion, disease prevention, family planning, and reproductive health.
• increase the understanding and treatment of tropical diseases

No applicants// Limit: 1 // Tickets Available: 1 

The Music Recording Program's objective is to increase the public's knowledge of and appreciation for contemporary American concert music and contemporary jazz through the documentation and distribution of commercial recordings.

Limit: 1 // PI: G. Sutphin (Molecular and Cellular Biology)

The University of Arizona Cancer Center (UACC) coordinates the internal selection process for this funding program, for more information please contact UACC-PreAward.

MKAF is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian, uterine or cancers predominantly affecting women. Grants will be awarded in the amount of $100,000 over a two- year period. PI must commit a minimum 5% effort.

No limit per institution* // 

*Eligibility note: PO has confirmed that the limitation applies to the lead PI, not the institution. That is, DOE wll accept multiple applications from a specific institution, but there can be only one application from an individual who is the lead PI. That individual could be a co-PI/collaborator on another submission from that same institution or on an application that is led by someone else at another institution.

The BER ESS program goal is to advance an integrated, robust, and scale-aware predictive understanding of terrestrial systems and their interdependent microbial, biogeochemical, ecological, hydrological, and physical processes. To support this goal, the program uses a systems approach to develop an integrative framework to elucidate the complex processes and controls on the structure, function, feedbacks, and dynamics of terrestrial systems, that span from molecular to global scales and extend from the bedrock through the soil, rhizosphere, and vegetation to the atmosphere. The ESS program scope advances foundational process knowledge with an emphasis on understudied ecosystems. Supported research emphasizes ecological and hydro-biogeochemical linkages among system components and characterization of processes across interfaces (e.g., terrestrial-aquatic, coastal, urban) to address key knowledge gaps and uncertainties across a range of spatial and temporal scales. Incorporation of scientific findings into process and system models is an important aspect of the ESS strategy, both to improve predictive understanding as well as to enable the identification of new research questions and directions.

Application Types:

Standard – Standard applications are solicited for research projects that may extend up to three years’ duration addressing a research project objective(s) associated with SRA #1 or SRA #2, as described below in this FOA. Standard applications must include significant new field experiments as part of the proposed activities, use observations and experimental outcomes to inform and/or improve models in a ModEx approach, and advance the understanding of ecosystem and/or watershed systems. Projects focused primarily on modeling or model development and/or those lacking substantial new empirical data collection are out of scope. Standard applications should have budgets commensurate with the scope of work (but no more than $1,000,000 in total costs); applications do not have to be proposed at the award ceiling but can and should include smaller-scope research applications with commensurate budgets. The potential impact, probability of success, and the risk-reward balance will be considered when making funding decisions.

Synthesis – Only Synthesis applications are solicited for SRA #3. Synthesis applications should propose new science that is focused on meta-analysis and synthesis research efforts that address development and testing of ESS-relevant hypotheses using existing data, and that have the potential for high impact regarding ESS research priorities. Synthesis awards will have a duration of up to two years and an award ceiling of $400,000 in total costs. Synthesis applications should target innovative questions that can be addressed by both interrogating and integrating existing data to address key knowledge gaps that are relevant and transferable across ecosystems and/or watershed systems. Synthesis applications may not request funding for collection of new data or field research, support for field-related supplies or equipment, travel to or maintenance of field sites or research facilities, or operational support for research networks.

No applicants// Limit: 1 // Tickets Available: 1

UArizona may submit one pre-application.

AHA Membership Requirement: Any individual applying as a Center Director or a Project Principal Investigator (PI) must be an AHA Professional Member before submitting a full proposal. (Membership is not required to submit a pre-proposal.) Join or renew when preparing an application in ProposalCentral, online, or by phone at 301-223-2307 or 800-787-8984. Membership processing may take 3-5 days; do not wait until the application deadline to renew or join.

Required Pre-Proposal 

Each Center Director is required to send a pre-proposal USE THIS LINK to provide the following:

• Name and institution of the Center Director and each Project PI
• Center title, and title and performance site of each proposed project

If required, the mechanism through which partnering requirements are being met. See “Additional Expectations and Opportunities” and “Institutional Eligibility/Location of Work” sections.

As part of the required Pre-Proposal, if the submitting institution or a partnering institution is not a research-intensive institution of higher learning, the lead for that institution must upload a letter from a Senior Institutional Official (e.g., president, provost, dean, etc.) indicating they meet the definition of a non-research-intensive institution as stated in the “Additional Expectations and Opportunities” section. 

AHA staff will review for compliance. A non-complying institution will not be permitted to submit a full proposal. This administrative review is part of the Pre-Proposal process, which is required and, though rare, may prevent an applicant from moving forward. Even though the Pre-Proposal is required, each Center and Project applicants should begin planning and designing their applications before the Pre-Proposal deadline to maximize the amount of time available to develop their full proposal.

Purpose
The American Heart Association (AHA) announces this Request for Proposals for the Strategically Focused Research Network (SFRN) on Inflammation in Cardiac and Neurovascular Disease.

THE ROLE OF INFLAMMATION IN CARDIAC AND NEUROVASCULAR DISEASE

Throughout the body, inflammation plays a crucial role in maintaining tissue homeostasis and initiating appropriate immune responses against pathogens or injury. However, dysregulation of inflammatory processes can lead to detrimental effects, contributing to the development and progression of many disease states, such as autoimmune conditions, cancer, diabetes, kidney disease and liver disease.1

The heart and nervous system are also subject to disease with dysregulation of the inflammatory system. Inflammatory myocarditis, characterized by inflammation of the myocardium, is more likely to occur in males compared to females.2 It is most commonly triggered by viral infection; triggering viruses include adenoviruses, enteroviruses, parvoviruses and coronaviruses (including SARS-CoV-2), among others.3  Less commonly, myocarditis is caused by bacterial or fungal infection or autoimmune diseases.  Of more recent note, it was discovered during the COVID-19 pandemic that vaccines developed against SARS-CoV-2, particularly those using mRNA technology, elicited myocarditis in a subset of vaccine recipients.4 The highest incidence (approximately 50 / 100,000) was found in men under 40. 

Myocarditis can be subclassified based on a number of characteristics. The most prominent symptoms are chest pain and dyspnea,5 and in many cases, myocarditis may resolve on its own. One notable exception is fulminant myocarditis, a rare and severe form of myocarditis that is responsible for a high proportion of cardiac-related deaths in young individuals.6 Acute myocarditis is defined as that for which symptoms are of recent onset, generally within a month or so. Inflammatory processes associated with myocarditis, such as infiltration of immune cells, release of pro-inflammatory cytokines, and oxidative stress, can lead to myocyte damage, fibrosis, and impaired contractility.3,7-8 Myocarditis that is associated with cardiac dysfunction and remodeling of the ventricle is referred to as inflammatory cardiomyopathy, a condition that is typically irreversible. It may result in arrhythmias, ventricular dysfunction or heart failure and requires lifelong therapy and/or heart transplant.

Within the nervous system, inflammation has been implicated in an array of pathologies, such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.9-10 Inflammation also plays a prominent role in stroke.11-13  A robust neuroinflammatory response is initiated following an ischemic event. Sex differences are also observed with stroke, with the risk being higher for females than males.14 The primary cause of this neuroinflammation is the activation of immune cells in the brain, including microglia and astrocytes. These cells are responsible for defending the brain against pathogens and injuries. However, under certain conditions, they can become overactivated and release inflammatory molecules. Neuroinflammation can have both beneficial and detrimental effects. In acute situations, neuroinflammation helps clear pathogens, promote tissue repair, and support the restoration of normal brain function. However, chronic or excessive neuroinflammation can damage neurons, impair synaptic communication, break down the blood-brain barrier, and disrupt the delicate balance of the brain's environment.11

CARDIOTOXICITY 
Cardiotoxicity describes a condition wherein a decrease in cardiac function results from administration of drugs or other agents. Currently, the term is largely identified with changes in cardiovascular function resulting from treatment with a number of cancer therapies. Whereas a decrease in left ventricular ejection fraction is the cardiac parameter most closely aligned with cardiotoxicity, additional cardiac effects (e.g., left ventricular systolic dysfunction, angina, and acute coronary syndrome) may also be characterized as cardiotoxicity.15 

There are several potential mechanisms underlying cardiotoxicity of chemotherapeutic agents, including inflammation. For example, use of chemotherapeutics of the anthracycline class, widely prescribed because of their efficacy against both solid and hematologic tumors, is associated with a high incidence of cardiotoxicity.16 Despite this effect of anthracyclines being described decades ago, the mechanism(s) underlying cardiotoxicity are not fully elucidated. Studies in more recent years do suggest, however, that at least part of the cardiotoxic actions of anthracyclines are related to inflammation.17 In addition, pre-clinical studies assessing effects of anti-inflammatory agents against anthracycline-induced cardiotoxicity have shown favorable results.18-19  Targeting inflammation thus holds promise for preventing or mitigating cardiotoxic effects of this class of chemotherapeutic. 

More contemporary cancer treatments also elicit adverse cardiac effects. Immune checkpoint inhibitors (ICIs), a new and promising class of anti-cancer drugs, may elicit a severe form of myocarditis.20 Whereas the incidence is relatively low, the mortality rate is high, due in part to the fact that many individuals present with a fulminant-like form of myocarditis. The mechanism underlying ICI-induced myocarditis remains unclear. The promise of this new class of cancer treatment will not be fully realized unless the mechanism is identified, which will facilitate therapeutic strategies to prevent or mitigate this severe adverse effect.   

While our understanding of the role inflammation plays in cardiac and brain dysfunction has grown considerably in recent years, several hindrances remain that preclude improved recognition and treatment of these conditions. For instance, significant gaps remain in understanding of the downstream signaling events and potential crosstalk; development of new animal and in vitro models would support these needs. In addition, notable opportunities for optimization of diagnostic capabilities exist, such as identification and assessment of biomarkers with improved specificity and development of improved imaging techniques. Clinical trials designed to assess outcomes more specifically for distinct types and/or stages of inflammatory conditions are also needed.